February 2025
Be Ready to Test and Treat for Common Respiratory Illnesses
The PREP Act extension allows pharmacists to order and administer COVID-19 tests through 2029 and more states are permitting pharmacists to screen and prescribe meds for influenza, strep throat, etc. Our Letter articles review when to consider treatment for these conditions, along with medication options and guidance to keep patients safe. We also sum up treatment recommendations, usual dosing, and approximate cost in a concise table. Readers can get more guidance in our resources, Antivirals for Influenza and Outpatient COVID-19 Treatment Options.
Read More:
Community Topic: Stay Current on H. Pylori Treatment Guidance
Recent guidelines are leading to a shift in the treatment of H. pylori. Plus, regimens are complex. Our Letter articles sort out preferred regimens for empiric and salvage treatment of H. pylori in an easy-to-interpret chart. We also bring up pros and cons of the various regimens to help guide shared-decision making. Readers can post our new H. Pylori Treatment Summary chart as a quick reference to preferred regimens and dig into our updated FAQ, Helicobacter pylori: From Diagnosis to Eradication, for a deeper dive into testing and treatment options.
Read More:
Hospital Pharmacy: Simplify IV N-Acetylcysteine for Acetaminophen Overdoses
N-Acetylcysteine (NAC) for acetaminophen poisoning has traditionally been given as a 3-bag regimen over 21 hours. Now the FDA recently approved an alternative 2-bag approach that many hospitals have been using off-label. Our Letter articles discuss how these regimens compare with regard to dosing, administration, patient outcomes, and safety. We also clarify when the 3-bag regimen is still preferred and provide practical advice on how to implement the newer NAC regimen and limit errors.
Read More:
Due to recent measles outbreaks, we wanted to revisit our article from March 2024, which remains the most current source of information and recommendations. Our Letter articles review symptoms of measles and what to do if you suspect one of your patients has measles. We also review options for postexposure prophylaxis. We emphasize when to give a measles-containing vaccine, such as MMR (measles/mumps/rubella) or MMRV (measles/mumps/rubella/varicella), and review who should not get a measles-containing vaccine. Our resource, Vaccine Adherence: Addressing Myths and Hesitancy, provides a checklist to support your discussions and tackle barriers.
Read More:
A federal judge ruled that apoaequorin (Prevagen) can no longer be marketed for improving memory or cognition. This will be a major shift in what consumers have been seeing in commercials, pharmacy signage, and online for almost 20 years. Our NatMed article explains that while this ruling may seem like a big change, the actual data haven’t shifted. There was never strong clinical evidence showing that apoaequorin improves memory or cognition. This is just one example of how dietary supplements are regulated differently than drugs. The FDA and FTC can only take action against manufacturers for safety concerns or misleading marketing claims AFTER they are on the market.
A federal judge ruled that apoaequorin (Prevagen) can no longer be marketed for improving memory or cognition. This will be a major shift in what consumers have been seeing in commercials, pharmacy signage, and online for almost 20 years. Our NatMed article explains that while this ruling may seem like a big change, the actual data haven’t shifted. There was never strong clinical evidence showing that apoaequorin improves memory or cognition. This is just one example of how dietary supplements are regulated differently than drugs. The FDA and FTC can only take action against manufacturers for safety concerns or misleading marketing claims AFTER they are on the market.
Listen to this month’s podcast episode, Notable New Meds of 2024, as two of our TRC Healthcare editors, Sara Klockars, PharmD, BCPS, and Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, discuss several novel drugs approved in 2024 and highlight some medications now available in a new dosage form. They’ll review efficacy, safety, and considerations for use with these new treatment options.
Pharmacist’s Letter and Prescriber Insights subscribers can get CE credit for listening to our Medication Talk podcast.
Listen to and watch this month’s episode, Hangover Remedies, as two of our TRC Healthcare editors, Steven Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, and Don Weinberger, PharmD, PMSP, separate fact from fiction. They’ll look at popular hangover remedies including natural products, hydration clinics, and more to see if there’s any proof behind the claims.
Listen to our latest episode, Managing Resistant Hypertension, as TRC Healthcare editor, Rachel Cole, PharmD, discusses the latest guidance.
Date: March 12 & 25, 2025
In this month’s live webinar, Meds for Opioid Use Disorder: Buprenorphine and Beyond, you’ll hear panelists discuss medications for management of opioid use disorder. They’ll also review strategies to optimize buprenorphine use and discuss the role of methadone and naltrexone.
Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:
February 2025 Live Webinars
Check out our Pharmacy Essential live CE webinars for March. Topics include:
*Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar.
Quickly find key clinical charts and visuals with our new Featured Charts & Graphics resource hub. Explore a collection of graphics, charts, and algorithms to stay on top of new drugs, the latest clinical recommendations, and help keep patients safe. Now available under the “Charts & Graphics” or “Browse” tab on your homepage!
Characteristics of Transdermal Patches and Dos and Don’ts With Patches
Our updated charts give advice about what to do if a patch becomes loose or falls off, as well as guidance about exposure to water. And readers can post our Dos and Don’ts checklist as a quick guide to important patient counseling points.
Comparison of Insulins
Our new, concise, and interactive chart compares available insulin products with regard to onset and duration of effect, formulations and approximate cost, and stability at room temperature.
By Adam West, Course and Curriculum Manager at CriticalPoint
In this month’s blog, Outsourced Suppliers and Shortages and Tariffs, Oh My!, Adam explores the latest updates on import tariffs and shares strategies to protect your pharmacy from potential supply chain disruptions. Learn how vendor evaluation and risk assessment for primary suppliers can help safeguard your operations.
By Adam West, Course and Curriculum Manager at CriticalPoint
In this month’s blog, Outsourced Suppliers and Shortages and Tariffs, Oh My!, Adam explores the latest updates on import tariffs and shares strategies to protect your pharmacy from potential supply chain disruptions. Learn how vendor evaluation and risk assessment for primary suppliers can help safeguard your operations.
As we've shared in previous newsletters, the NatMed Pro platform will be changing in the coming months. While users will continue accessing the natural database as usual, the experience will be significantly improved.
With a fresh, clean design and an intuitive layout, the new platform will offer enhanced performance and elevated functionality, including:
To ensure you and your team can ease into this transition seamlessly, we created a list of FAQs to help answer some of the more-immediate common questions. Click here to view the FAQs.
As we've shared in previous newsletters, the NatMed Pro platform will be changing in the coming months. While users will continue accessing the natural database as usual, the experience will be significantly improved.
With a fresh, clean design and an intuitive layout, the new platform will offer enhanced performance and elevated functionality, including:
To ensure you and your team can ease into this transition seamlessly, we created a list of FAQs to help answer some of the more-immediate common questions. Click here to view the FAQs.
Between keeping up with the latest state requirements and managing multiple clinical teams across multiple states, CE/CME compliance can be a daunting task. But it doesn't have to be with NetCE All Access!
NetCE All Access empowers your teams to improve patient care while effectively satisfying their professional requirements through evidence-based and relevant CE/CME. Our one-platform solution allows you to consolidate multiple providers, easily report completions, and assign required CE/CME and training, eliminating the hassles of maintaining and managing CE/CME for clinicians across multiple professions and states.
NetCE All Access Simplifies Tedious Tasks
Pharmacy Technicians University (PTU) provides an affordable, easy-to-manage training program that prepares technicians for certification while also enhancing knowledge retention, ensuring they are fully equipped to pass the PTCE with confidence. As the most trusted resource for training both new and experienced technicians, PTU keeps your pharmacy’s program updated with the latest state requirements and national standards.
PTU offers:
Contact us to boost your pharmacy's offerings and provide your technicians with a high-quality, meaningful education with PTU.
Join us on Wednesday, March 12, 2025 from 2:00 - 2:30 PM EST for a free live demo webinar. Listen in as our Solutions Executive, Keith Marston, demonstrates how the Bula platform is essential for keeping track of all of the changes that could impact your pharmacy during the upcoming legislative sessions.
Webinar Agenda:
Who Should Attend:
Executives and clinical leadership, management, and administrators responsible for ensuring compliance for safe practice and effective patient care.
All attendees will receive access to a free trial of Bula, the largest pharmacy law and regulatory database.
*This webinar does not offer CE credits for attending.
Join us on Wednesday, March 12, 2025 from 2:00 - 2:30 PM EST for a free live demo webinar. Listen in as our Solutions Executive, Keith Marston, demonstrates how the Bula platform is essential for keeping track of all of the changes that could impact your pharmacy during the upcoming legislative sessions.
Webinar Agenda:
Who Should Attend:
Executives and clinical leadership, management, and administrators responsible for ensuring compliance for safe practice and effective patient care.
All attendees will receive access to a free trial of Bula, the largest pharmacy law and regulatory database.
*This webinar does not offer CE credits for attending.